WBR0660: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) (Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Biostatistics/ Epidemiology |SubCategory=Gastrointestinal |MainCategory=Biostatistics/ Epidemiology ...") |
Sergekorjian (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor={{ | |QuestionAuthor={{SSK}} (Reviewed by Serge Korjian) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|Prompt=A new vaccine is being developed for the prevention of Hepatitis E. In phase | |Prompt=A new vaccine is being developed for the prevention of Hepatitis E. In a phase 2 clinical trial, 100 individuals are randomized to receive either the vaccine or a placebo. Out of the 50 patients that received the vaccine 1 went on to develop Hepatitis E in the 6 month follow up after the vaccination. In the placebo group 7 out of 50 patients developed Hepatitis. What is the number needed to treat for this newly developed vaccine according to the results of this trial? | ||
|Explanation=The number needed to treat refers to the number of patients required to receive a certain treatment for 1 patient to benefit from it. It is usually the inverse of the absolute risk reduction(ARR). The ARR can be calculated as follows: | |Explanation=The number needed to treat refers to the number of patients required to receive a certain treatment for 1 patient to benefit from it. It is usually the inverse of the absolute risk reduction(ARR). The ARR can be calculated as follows: | ||
[[Image:ARRequation.jpg|600px]] | [[Image:ARRequation.jpg|600px]] | ||
|AnswerA=0.14 | |AnswerA=0.14 | ||
|AnswerB=7.14 | |AnswerB=7.14 | ||
| Line 32: | Line 19: | ||
|AnswerD=300 | |AnswerD=300 | ||
|AnswerE=Data insufficient to calculate | |AnswerE=Data insufficient to calculate | ||
|EducationalObjectives=The number needed to treat is calculated by finding the inverse of the absolute risk reduction (1/ARR) | |||
|RightAnswer=C | |RightAnswer=C | ||
|WBRKeyword=Number needed to treat | |WBRKeyword=Number needed to treat, Absolute risk reduction | ||
|Approved= | |Approved=Yes | ||
}} | }} | ||
Revision as of 01:12, 16 September 2014
| Author | [[PageAuthor::Serge Korjian M.D. (Reviewed by Serge Korjian)]] |
|---|---|
| Exam Type | ExamType::USMLE Step 1 |
| Main Category | |
| Sub Category | SubCategory::Gastrointestinal |
| Prompt | [[Prompt::A new vaccine is being developed for the prevention of Hepatitis E. In a phase 2 clinical trial, 100 individuals are randomized to receive either the vaccine or a placebo. Out of the 50 patients that received the vaccine 1 went on to develop Hepatitis E in the 6 month follow up after the vaccination. In the placebo group 7 out of 50 patients developed Hepatitis. What is the number needed to treat for this newly developed vaccine according to the results of this trial?]] |
| Answer A | AnswerA::0.14 |
| Answer A Explanation | AnswerAExp:: |
| Answer B | AnswerB::7.14 |
| Answer B Explanation | AnswerBExp:: |
| Answer C | AnswerC::8.33 |
| Answer C Explanation | AnswerCExp:: |
| Answer D | AnswerD::300 |
| Answer D Explanation | AnswerDExp:: |
| Answer E | AnswerE::Data insufficient to calculate |
| Answer E Explanation | AnswerEExp:: |
| Right Answer | RightAnswer::C |
| Explanation | [[Explanation::The number needed to treat refers to the number of patients required to receive a certain treatment for 1 patient to benefit from it. It is usually the inverse of the absolute risk reduction(ARR). The ARR can be calculated as follows:
|
| Approved | Approved::Yes |
| Keyword | WBRKeyword::Number needed to treat, WBRKeyword::Absolute risk reduction |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |
